WWRL yields 21505.38% · PFE yields 6.13%● Live data
📍 WWRL pulled ahead of the other in Year 1
Combined, WWRL + PFE cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of WWRL + PFE for your $10,000?
World Wireless Communications, Inc. engages in the design and development of wired and wireless telemetry and remote control systems. Its products and services allow data from remote devices to be accessed via a secure, encrypted Internet connection using a standard Web browser in automatic meter reading and facilities management fields. The company operates through the X-traWeb products and Radio product segments. It offers X-Node, a micro-controller, which collects, processes, and transmits information to provide wired or wireless Internet access; and X-Gate product, which serves as a data collecting and transmitting system on a wired or wireless basis through the Internet to a Web and data-hosting server. The company also provides a line of 900 MHz spread spectrum radios, including the 900 SS Hopper, a frequency hopping spread spectrum radio that offers communication in various environments; and 900 SS MicroHopper that provides a smaller form-factor and lower power-consumption for short-range applications. In addition, it offers the 900 SS Direct—either as a direct sequence or frequency-hopping combined transmitter and receiver for transmitting data up to 40 kilometers, line of sight. World Wireless Communications, Inc. also manufactures and sells antennas. The company maintains approximately 80 specialty antennas for use in law enforcement, marine, and custom applications. World Wireless Communications, Inc. is based in Greenwood Village, Colorado.
Full WWRL Calculator →Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.
Full PFE Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.